Attana AB engages in the development of biosensors for pharmaceutical, diagnostic, and academic societies. Its biosensors can be used to determine specificity, kinetics, and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses, and bacteria. The company was founded by Bo Teodor Aastrup and Samir Christian Fostock in September 2002 and is headquartered in Stockholm, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company